Drug Coated Stents May Be Harmful To Patients!

Drug-coated stents, sold in the United States byfrom a bare stent? A preliminary FDA staff analysis
Johnson & Johnson and Boston Scientific Corp haveconcluded that there was a "small but significant" risk
hailed as a major advance just 3 years ago are nowof blood clots appearing a year or more after a
being blamed to cause blood clots and otherdrug-coated stent is implanted. Nevertheless, it was
complications in certain high-risk cases and patients.not clear if the long-term risk of dying or having a
What is stent? It is a short narrow metal tube in theheart attack was elevated.
form of a mesh that is inserted into artery to keepNearly 6 million patients worldwide have received
the previously blocked passageway open. Using drugdrug-coated stents and the market is worth nearly
coating on the stent can lower the chances of anUS$6 billion a year, according to an estimate by JP
artery closing again, a problem reported with about aMorgan analysts.
quarter of stents without drug.Makers of drug-coated stents maintain their stands
United States advisers have now started to considerthat the drug-coated versions continue to offer
the risks of drug-coated stents implanted in millions ofadvantages over bare-metal alternatives. Boston
heart patients, examining evidence showing theScientific has revealed that it found a slight increase
devices may lead to dangerous blood clots.in blood clots with its Texus drug-coated stent, but
This surfaced problem is viewed as a public issue ofno higher rate of heart attacks or deaths. Johnson &
great importance and the agency concerned doesJohnson has announced that the data so far shows
not want to wait until they had every piece ofno significant difference in the risk of blood clots
information before trying to provide guidance aboutbetween its Cypher drug-coated stent and
the stent use. The Food and Drug Administrationbare-metal versions.
(FDA) has in fact set up a panel of outside expertsIn the light of the possible danger of blood clots
to go through varying studies and provide advicecaused by drug-coated stents, Abbott Laboratories
about the level of risk and which patients should beand Medtronic Inc, which market their versions of
candidates for drug-coated stents.drug-coated stents in other countries, are aiming for
But here is the key question: how can we weight theUnited States launches as early as the middle of next
chances of blood clots against the risk of re-closingyear.